Skip to main content

Catalent, Inc.

CTLTDelisted Dec 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001596783

Catalent, Inc. was delisted on Dec 18, 2024; its insiders filed their last Form 4 on Dec 18, 2024; 473 institutions reported holding it in 13F filings for Q3 2024, worth $10.8B in total; Elliott Investment Management was the only superinvestor holding it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Oct 8, 2026, 1:39 PM ET

Revenue flow, FY2024

Where the revenue went in FY2024, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.

Net loss for FY2024: $1.04B (23.8% of revenue).

Income statement

Each column is one fiscal year, newest first.

Income statement of Catalent, Inc., annual
Line itemFY2024FY2023FY2022FY2021FY2020
Period endJun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020
Filing10-K10-K10-K/A10-K10-K
ReportedAug 29, 2024Aug 29, 2023Aug 29, 2022Aug 30, 2021Jul 30, 2020
Revenue$4.38B$4.26B$4.80B$4.00B$3.09B
Cost of revenue$3.43B$3.22B$3.19B$2.65B$2.11B
Gross profit$953.0M$1.04B$1.61B$1.35B$983.3M
Research and development$17.0M$18.0M$23.0M$21.0M–
Selling, general and administrative$935.0M$829.0M$844.0M$687.0M$577.9M
Operating income-$749.0M-$163.0M$730.0M$828.0M$394.4M
Income tax$16.0M-$86.0M$80.0M$130.0M$39.7M
Net income-$1.04B-$256.0M$499.0M$585.0M$220.7M
EPS, basic$-5.76$-1.42$2.74$3.15$1.16
EPS, diluted$-5.76$-1.42$2.73$3.11$1.14
Weighted shares, basic181.0M181.0M176.0M168.0M149.8M
Weighted shares, diluted181.0M181.0M178.0M170.0M152.3M
Margins and growth
Gross margin21.8%24.4%33.6%33.8%31.8%
Operating margin-17.1%-3.8%15.2%20.7%12.7%
Net margin-23.8%-6.0%10.4%14.6%7.1%
Revenue growth, year over year+2.8%−11.2%+20.1%+29.2%+22.9%
Net income growth, year over year–−151.3%−14.7%+165.1%+60.6%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Catalent, Inc., annual
Line itemFY2024FY2023FY2022FY2021!FY2020!
Period endJun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020
Filing10-K10-K10-K/A10-K10-K
ReportedAug 29, 2024Aug 29, 2023Aug 29, 2022Aug 30, 2021Jul 30, 2020
Cash and equivalents$289.0M$280.0M$449.0M$896.0M$953.2M
Accounts receivable$921.0M$1.00B$1.05B$1.01B$838.1M
Inventory$574.0M$777.0M$702.0M$563.0M$323.8M
Total current assets$2.60B$2.69B$2.92B$2.92B$2.29B
Property, plant and equipment$3.64B$3.68B$3.13B$2.52B$1.90B
Goodwill$2.33B$3.04B$3.01B$2.52B$2.47B
Intangible assets$841.0M$980.0M$1.06B$817.0M$888.7M
Total assets$9.75B$10.8B$10.5B$9.11B$7.78B
Accounts payable$361.0M$424.0M$421.0M$385.0M$321.0M
Short-term debt$48.0M$536.0M$31.0M$75.0M$72.9M
Total current liabilities$1.03B$1.53B$1.10B$1.20B$893.2M
Total liabilities$6.15B$6.17B$5.73B$4.84B$4.27B
Shareholders' equity$3.60B$4.61B$4.78B$3.92B$2.90B

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Catalent, Inc., annual
Line itemFY2024FY2023FY2022FY2021FY2020
Period endJun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020
Filing10-K10-K10-K/A10-K10-K
ReportedAug 29, 2024Aug 29, 2023Aug 29, 2022Aug 30, 2021Jul 30, 2020
Operating cash flow$268.0M$254.0M$439.0M$433.0M$440.3M
Capital expenditures$327.0M$576.0M$660.0M$686.0M$465.8M
Free cash flow-$59.0M-$322.0M-$221.0M-$253.0M-$25.5M
Depreciation and amortization$489.0M$422.0M$378.0M$289.0M$253.7M
Stock-based compensation$68.0M$35.0M$54.0M$51.0M$48.1M
Investing cash flow-$327.0M-$955.0M-$1.88B-$649.0M-$827.5M
Financing cash flow$74.0M$521.0M$1.03B$142.0M$1.00B
Net change in cash$9.00M-$169.0M-$447.0M-$57.0M$607.8M
Ratio
Stock-based compensation, % of revenue1.6%0.8%1.1%1.3%1.6%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for Catalent, Inc. by cover date
Cover dateShares outstandingChange in a yearFiling
Oct 29, 2024181.5M+0.5%SEC
Oct 23, 2024181.5M+0.5%SEC
Aug 22, 2024181.5M+0.5%SEC
Apr 25, 2024181.0M+0.4%SEC
Jan 31, 2024180.7M+0.4%SEC
Oct 31, 2023180.6M+0.4%SEC
Aug 18, 2023180.6M+0.4%SEC
Apr 30, 2023180.3M+0.6%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
  • A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.